BPG is committed to discovery and dissemination of knowledge
Articles in Press
2/4/2026 10:02:17 AM | Browse: 2 | Download: 0
Publication Name World Journal of Gastroenterology
Manuscript ID 111455
Country United States
Category Gastroenterology & Hepatology
Manuscript Type Basic Study
Article Title Optimal cannabinoid-terpene combination ratios suppress mutagenicity of gastric reflux in normal and metaplastic esophageal cells
Manuscript Source Unsolicited Manuscript
All Author List Aaron Goldman, Gabriel Gonzalez, Svetlana A Karpova, Leutz Buon, Masood A Shammas, Hiroshi Mashimo, Markus H Frank and Natasha Y Frank
Funding Agency and Grant Number
Funding Agency Grant Number
National Institutes of Health No. R01EY025794
National Institutes of Health No. R01HL161087
National Institutes of Health No. P01AG071463
National Institutes of Health No. 1K01CA226375-01A1
Veterans Administration Research and Development Merit Review Awards No. 1I01BX000516
Veterans Administration Research and Development Merit Review Awards No. 1I01RX000989
Veterans Administration Research and Development Merit Review Awards No. 1I01BX006004
Corresponding Author Natasha Y Frank, Department of Medicine, VA Boston Healthcare, 1400 VFW Parkway, Building 3, Suite 2A105, Boston, MA 02132, United States. nyfrank@bwh.harvard.edu
Key Words Gastroesophageal reflux disease; Bile acids; DNA damage; New therapeutics; Cannabinoids; Reactive oxygen species; DNA repair
Core Tip Activation of the endocannabinoid system (ECS) with specific cannabinoid-terpene combinations and ratios has been shown to protect esophageal cells from bile acid-induced DNA damage and mutations, which are key drivers of esophageal adenocarcinoma (EAC). In vitro models revealed that a 1:5 ratio of cannabigerol to phytol or β-caryophyllene significantly reduced DNA damage and oxidative stress while preserving mitochondrial function. This combination also promoted apoptosis in damaged cells, while the ECS receptor expression patterns correlated with EAC progression. These findings indicate that ECS modulation may represent a novel therapeutic strategy for EAC and related conditions.
Citation Goldman A, Gonzalez G, Karpova SA, Buon L, Shammas MA, Mashimo H, Frank MH, Frank NY. Optimal cannabinoid-terpene combination ratios suppress mutagenicity of gastric reflux in normal and metaplastic esophageal cells. World J Gastroenterol 2026; In press
Received
2025-07-01 09:47
Peer-Review Started
2025-07-01 09:48
First Decision by Editorial Office Director
2025-07-29 09:48
Return for Revision
2025-07-29 09:48
Revised
2025-09-12 14:45
Publication Fee Transferred
Second Decision by Editor
2026-02-04 02:41
Second Decision by Editor-in-Chief
Final Decision by Editorial Office Director
2026-02-04 10:02
Articles in Press
2026-02-04 10:02
Edit the Manuscript by Language Editor
Typeset the Manuscript
ISSN 1007-9327 (print) and 2219-2840 (online)
Open Access This article is an open-access article that was selected by an in-house editor and fully peer-reviewed by external reviewers. It is distributed in accordance with the Creative Commons Attribution NonCommercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial. See: https://creativecommons.org/Licenses/by-nc/4.0/
Copyright © The Author(s) 2026. Published by Baishideng Publishing Group Inc. All rights reserved.
Permissions For details, please visit: http://www.wjgnet.com/bpg/gerinfo/207
Publisher Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
Website http://www.wjgnet.com